Detailed description page of SalivaDB

This page displays user query in tabular form.

SAL_15775 details
Primary information
SALIDSAL_15775
Biomarker nameLeptin (Obese protein) (Obesity factor)
Biomarker TypeNA
Sampling MethodAge 31-65
Collection MethodWhole unstimulated salivary samples (~2ml) were collected by modified draining method. 4 Patients were asked to expectorate into disposable polypropylene tubes every 30 sec over a period of 5 min.
Analysis MethodELISA
Collection SiteWhole Saliva
Disease CategoryDental Disorder
Disease/ConditionChronic periodontitis
Disease SubtypeNA
Fold Change/ Concentration-1.42
Up/DownregulatedDownregulated
ExosomalNA
OrganismHomo sapiens
PMID25537001
Year of Publication2014
Biomarker IDP41159
Biomarker CategoryProtein
SequenceMHWGTLCGFLWLWPYLFYVQAVPIQKVQDDTKTLIKTIVTRINDISHTQSVSSKQKVTGLDFIPGLHPILTLSKMDQTLAVYQQILTSMPSRNVIQISNDLENLRDLLHVLAFSKSCHLPWASGLETLDSLGGVLEASGYSTEVVALSRLQGSLQDMLWQLDLSPGC
Title of studySalivary and serum leptin concentrations in patients with chronic periodontitis
Abstract of studyBACKGROUND: The discovery of leptin has led to the elucidation of a robust physiologic system that not only maintains fat stores but is also an integral part of the host defense mechanism. However, leptin concentrations in the saliva of patients with chronic periodontitis (CP) has not been explored despite the potential role of salivary biomarkers in determining the presence, risk, and progression of periodontal disease.METHODS: Eighty-four participants (44 with generalized severe CP and 40 without periodontitis) were enrolled. For each patient, the values of periodontal parameters were recorded, such as plaque index (PI), gingival index (GI), probing depth (PD), clinical attachment loss (AL), and percentage of sites with bleeding on probing (BOP) and clinical AL ≥5 mm. Saliva and serum samples were collected to estimate the leptin concentrations using enzyme-linked immunosorbent assay kits. Statistical analysis was performed using software.RESULTS: Participants with CP demonstrated significantly higher BOP, PI, GI, and percentage of sites with clinical AL >5 mm (P <0.05). Leptin was detectable in all the clinical samples. Salivary leptin concentrations in patients with CP were significantly lower than in healthy volunteers (6,200.61 ± 2,322.11 versus 8,799.60 ± 901.70 pg/mL), whereas serum leptin concentrations were significantly higher in patients with CP than in healthy volunteers (11,600.00 ± 1,705.01 versus 7,616.62 ± 1,169.83 pg/mL). In addition, the results reflected a significant negative correlation of salivary leptin and a positive correlation of serum leptin with PD (P <0.05).CONCLUSION: The results suggest that leptin concentrations in saliva and serum are significantly altered in CP and relate closely to current disease activity; however, further studies are needed to confirm the findings.